During this session, the panelists discussed how stakeholders in the clinical research market can leverage new technologies to better identify subjects, optimize trial conduct and reduce costs. For ...

There is an explosion of innovation in drug development. In 2023, the FDA approved 55 novel drugs. There were five approved gene therapies for rare diseases, including the first-ever FDA-approved ...

Increasing costs, complexity, regulatory demands and decentralization of clinical trials are driving PE dealmakers to invest more in designers of clinical research technologies. Tech providers and ...

Management to Engage with Global Clinical Research Leaders Ahead of Phase 2a Trial of Concussion Treatment Sarasota, Fla., ...

Clinical research sites face an information challenge that hinders efficiency and collaboration. As trial complexity increases, the multiple logins, devices, and spreadsheets site staff use to execute ...

At Inventus, we believe in creating solutions that simplify the complexities of device provisioning in the world of clinical trials. Founded in 2020, we are the world’s only Original Equipment ...

New integrations with industry leaders in EDC, eConsent, IRT/RTSM, eCOA, payments, and patient engagement expands Advarra's connected ecosystem, giving sponsors, CROs, and research sites secure, ...

In the clinical research industry, our mission is simple: to make the world a healthier place. For treatments to be effective and safe for all patients regardless of race, ethnicity or other factors, ...

Management reaffirmed the midpoint of guidance for adjusted operating income and adjusted earnings per share while narrowing each range. Rodriguez stated, "We now anticipate full year adjusted ...